Literature DB >> 18520348

AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.

Florence Huber1, Matthieu Nacher, Christine Aznar, Magalie Pierre-Demar, Myriam El Guedj, Tania Vaz, Vincent Vantilcke, Abba Mahamat, Christian Magnien, Elodie Chauvet, Bernard Carme, Pierre Couppié.   

Abstract

OBJECTIVE: Histoplasma capsulatum var. capsulatum infection is a major AIDS-defining illness in French Guiana. Although it affects South and Central American countries, the number of published cases is low. We present the largest series of AIDS-related histoplasmosis. The aim of this work is to describe clinical features and to help optimize investigations in settings where antigen detection methods are not available.
DESIGN: Two hundred cases of AIDS-related histoplasmosis, diagnosed in the hospitals of French Guiana, were included retrospectively between 1982 and 2007.
RESULTS: At the time of diagnosis, 92% of patients did not receive highly active antiretroviral therapy. CD4 cell count was less than 100 cells/microl for 80% of them. Most patients had fever, lymphadenopathies, and pulmonary and digestive symptoms. Neurological signs and skin/mucosal locations were less common. Other opportunistic infections were associated in 36.6% of cases (mostly tuberculosis). In most of the patients, lactic dehydrogenase was at least four times the normal value, and there was a moderate increase of aspartate aminotransaminase but not alanine aminotransaminase levels. Bone marrow aspirations were useful, but cultures of liver and lymphadenopathy specimens were the most contributive. Following treatment initiation, 17.5% died within a month. Presumptive treatment was started before diagnostic confirmation in 14.3% of the cases.
CONCLUSION: In high prevalence settings, histoplasmosis often revealed AIDS in severely immunodeficient and poorly followed patients. In the absence of a quick sensitive technique, skin smear and fungal tissue cultures are contributive. Nevertheless, given the diagnostic delays and the poor prognosis, presumptive treatment with amphotericin B-containing regimens should be recommended when clinical and epidemiological contexts are evocative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520348     DOI: 10.1097/QAD.0b013e3282ffde67

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  35 in total

1.  Histoplasmosis infections worldwide: thinking outside of the Ohio River valley.

Authors:  Nathan C Bahr; Spinello Antinori; L Joseph Wheat; George A Sarosi
Journal:  Curr Trop Med Rep       Date:  2015-06-01

2.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis.

Authors:  Mathieu Nacher; Antoine Adenis; Leila Adriouch; Julie Dufour; Emmanuelle Papot; Matthieu Hanf; Vincent Vantilcke; Mélanie Calvez; Christine Aznar; Bernard Carme; Pierre Couppié
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

4.  Histoplasmosis in HIV-Infected Patients: Epidemiological, Clinical and Necropsy Data from a Brazilian Teaching Hospital.

Authors:  Alessandro Henrique Damasceno-Escoura; Delio José Mora; Anderson Clayton Cardeal; Júlio Cesar Berto-Nascimento; Renata Margarida Etchebehere; Antônio Carlos Oliveira de Meneses; Sheila Jorge Adad; Adilha Misson Rua Micheletti; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2020-02-20       Impact factor: 2.574

5.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Authors:  Diego H Caceres; Angela M Tobón; Angela Ahlquist Cleveland; Christina M Scheel; Dedsy Y Berbesi; Jesús Ochoa; Angela Restrepo; Mary E Brandt; Tom Chiller; Beatriz L Gómez
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

6.  Diagnostic Methods for Histoplasmosis: Focus on Endemic Countries with Variable Infrastructure Levels.

Authors:  Christina M Scheel; Beatriz L Gómez
Journal:  Curr Trop Med Rep       Date:  2014-04-08

7.  Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study.

Authors:  Antoine Adenis; Mathieu Nacher; Matthieu Hanf; Célia Basurko; Julie Dufour; Florence Huber; Christine Aznar; Bernard Carme; Pierre Couppie
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

8.  Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients.

Authors:  Karen Arango-Bustamante; Angela Restrepo; Luz Elena Cano; Catalina de Bedout; Angela Maria Tobón; Angel González
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

9.  Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America.

Authors:  Cesar Muñoz; Beatriz L Gómez; Angela Tobón; Karen Arango; Angela Restrepo; Margarita M Correa; Carlos Muskus; Luz Elena Cano; Angel González
Journal:  Clin Vaccine Immunol       Date:  2009-11-25

Review 10.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.